FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease

  • 2 months ago
Alzhemers dsease causes th e Brain to shrink and Brain cells to eventually Die,and most common cause of Dementia-Now this drug if started in early stage of Dementia can prevent further damage to Brain cells and mprove Dementia.

Recommended